Hikma to buy Egypt's Alkan Pharma for $60.5 mln

LONDON Thu Aug 9, 2007 7:14am BST

Related Topics



LONDON Aug 9 (Reuters) - Jordanian drugmaker Hikma Pharmaceuticals Plc (HIK.L) said on Thursday it had agreed to buy Alkan Pharma for $60.5 million cash to enter the Egyptian pharmaceuticals market.

Hikma said the deal was scheduled to complete in the second half of this year and would be funded by debt.


After wave of QE, onus shifts to leaders to boost economy

DAVOS, Switzerland - Central banks have done their best to rescue the world economy by printing money and politicians must now act fast to enact structural reforms and pro-investment policies to boost growth, central bankers said on Saturday.